Epidemiology

Saturday, May 12, 2018: 11:30 AM-1:30 PM
Hall Grote Zaal (de Doelen ICC Rotterdam)
11:30 AM
184.105
105 A Comparison of ASD Screening in Toddlers By Global Developmental Screening and the Modified Checklist for Autism in Toddlers (M-CHAT)
O. Kerub E. J. Haas G. Meiri N. Davidovitch I. Menashe
11:30 AM
184.106
106 A Population-Based Study of Traffic-Related and Outdoor Air Pollution during Pregnancy and Autism in Denmark
B. Ritz Q. Yan Z. Liew X. Cui M. Ketzel O. Raaschou-Nielsen
11:30 AM
184.107
107 Adapting the Eleat (Early Life Exposure Assessment Tool) to Portugal – a Pilot Study to Tackle Gene-Environment Interactions in Autism Spectrum Disorder
C. Rasga J. Santos A. L. Lopes A. R. Marques J. Vilela M. Asif C. K. Walker R. J. Schmidt A. M. Vicente
11:30 AM
184.108
108 Exploring Gender Ratio Time Trends in Australian Children with Autism Spectrum Disorder Using Medicare Data
T. May K. Williams
11:30 AM
184.109
109 Classifying Autism Spectrum Disorder By Severity of Functional Limitations: Results from a Large Population-Based Study
M. S. Durkin M. J. Maenner S. Furnier P. Imm D. Christensen E. Rubenstein N. Dowling
11:30 AM
184.110
110 ASD Screening Using Social Communication Questionnaires (SCQ) in 93 Primary Schools in Qatar
F. Alshaban E. Fombonne M. Aldosari I. Ghazal
11:30 AM
184.111
111 Assessment of Racial and Ethnic Bias in Autism Spectrum Disorder Prevalence Estimates from a U.S. Surveillance System
P. Imm T. C. White M. S. Durkin
11:30 AM
184.112
112 Autism Diagnostic Timeline: No Disparities between Hispanic and Non-Hispanic White Populations in Western New York
J. Herrera M. Anto-Ocrah S. Hyman
11:30 AM
184.113
113 Autism Prevalence in Union County New Jersey, 2000-2014
J. Shenouda W. Zahorodny
11:30 AM
184.114
114 Autism Spectrum Disorder Prevalence in Immigrant Communities in Minnesota
J. Poynter E. Hallas-Muchow J. A. Hall-Lande A. N. Esler A. Gulaid A. Hewitt
11:30 AM
184.115
115 Autism-Associated DNA Methylation at Birth from Multiple Tissues Is Enriched for Autism Genes in the Early Autism Risk Longitudinal Investigation (EARLI)
K. M. Bakulski M. D. Fallin A. P. Feinberg J. I. Feinberg I. Hertz-Picciotto L. A. Croen C. J. Newschaffer S. Brown J. Dou M. Aung
11:30 AM
184.116
116 Changes in the Prevalence of Autism Spectrum Disorder in Utah: A Cohort Approach
A. V. Bakian C. A. Palmer C. Kingsbury N. Taxin W. M. McMahon D. A. Bilder
11:30 AM
184.117
117 Demographic, Diagnostic, and Clinical Characteristics of Adult Participants in the SPARK ASD Cohort
H. Zaydens L. A. Green Snyder A. Daniels P. Feliciano W. K. Chung
11:30 AM
184.118
118 Does Maternal Prescription Opioid Use during Pregnancy Increase a Child’s Risk of ASD or Developmental Disability?
E. Rubenstein J. C. Young L. A. Croen C. DiGuiseppi N. Dowling L. C. Lee L. Schieve L. Wiggins J. Daniels
11:30 AM
184.119
119 Advanced Maternal Age Is Not Independently Associated with Age at First Evaluation That Notes Autism Traits Among Children with ASD.
E. Rubenstein M. S. Durkin R. A. Harrington R. S. S. Kirby L. Schieve J. Daniels
11:30 AM
184.120
120 Green Space Exposure Predicts Anxiety and Conduct Problems in Youth with ASD
B. Barger L. Larson S. Ogletree D. Roberts J. Torquati S. Rosenberg C. Johnson-Gaither J. M. Bartz E. Moody A. Gardner A. Schutte
11:30 AM
184.121
121 Incomplete Vaccination and Risk of Autism Spectrum Disorder
B. Kim M. Ha Y. S. Kim Y. J. Koh H. J. Kwon M. H. Lim K. C. Paik P. S. Hong B. L. Leventhal
11:30 AM
184.122
122 Infection and Fever during Pregnancy and Risk for Autism: A Systematic Review and Meta-Analysis
A. Silberman N. Tioleco K. Stratigos S. Banerjee-Basu M. Spann A. Whitaker J. B. Turner
11:30 AM
184.123
123 Interaction between Manganese and GSTP1 in Relation to Autism Spectrum Disorder While Controlling for Exposure to Mixture of Lead, Mercury, Arsenic, and Cadmium
M. H. Rahbar M. E. Samms-Vaughan M. Lee M. A. Bach J. Bressler M. Hessabi M. L. Grove S. Pellington C. Coore Desai J. A. T. Reece K. A. Loveland E. Boerwinkle
11:30 AM
184.124
124 Maternal Anxiety and Depression Are Associated with Autism Spectrum Disorder Phenotypes in Preschol Children
L. Wiggins E. Rubenstein J. Daniels C. DiGuiseppi M. Yeargin-Allsopp L. Schieve L. Tian K. R. Sabourin E. Moody J. A. Pinto-Martin N. Reyes S. E. Levy
11:30 AM
184.125
125 The Influence of Diagnostic Criteria on Autism Spectrum Disorder Classification: Findings from the Metropolitan Atlanta Developmental Disabilities Surveillance Program, 2012
L. Wiggins D. Christensen J. Baio
11:30 AM
184.126
126 Maternal Cannabis Use in Pregnancy and Autism Spectrum Disorder in the Charge Study
P. Krakowiak R. J. Schmidt D. Tancredi R. L. Hansen S. Ozonoff I. Hertz-Picciotto C. K. Walker
11:30 AM
184.127
127 Maternal Metabolic Conditions and ASD: Comparing Associations from High-Risk and General Populations
P. Krakowiak D. Tancredi R. L. Hansen I. Hertz-Picciotto C. K. Walker
11:30 AM
184.128
128 Maternal Exposures Associated with Autism Spectrum Disorder in Jamaica
M. A. Bach M. E. Samms-Vaughan M. Lee J. Bressler M. Hessabi M. L. Grove S. Pellington C. Coore Desai J. A. T. Reece K. A. Loveland E. Boerwinkle M. H. Rahbar
11:30 AM
184.129
129 Maternal Infection and Fever during Pregnancy and Risk of Autism Spectrum Disorder: Findings from the Study to Explore EARLY Development (SEED)
L. A. Croen Y. Qian P. Ashwood O. Zerbo D. Schendel J. A. Pinto-Martin M. D. Fallin S. E. Levy L. Schieve M. Yeargin-Allsopp K. R. Sabourin
11:30 AM
184.130
130 Maternal Prenatal Vitamin Use and Risk for Autism Spectrum Disorder in the Marbles Prospective Study of Enriched-Risk Siblings
R. J. Schmidt A. M. Iosif E. Angel S. Ozonoff
11:30 AM
184.131
131 Maternal Thyroid Anomalies and Risk of ASD
R. S. Rotem G. Chodick M. Davidovitch R. Hauser B. A. Coull G. Koren M. Weisskopf
11:30 AM
184.132
132 Maternal Vitamin D Levels during Pregnancy and Autism Spectrum Disorders (ASD)
G. C. Windham M. Pearl V. Poon J. Carver D. Eyles K. Lyall K. L. Jones M. Kharrazi L. A. Croen
11:30 AM
184.133
133 Mental Comorbidities, Psychotropic Medication Use and Healthcare Resource Use in Autism Spectrum Disorder: A Matched Cohort Study in the United Kingdom.
R. Houghton C. Liu F. Bolognani
11:30 AM
184.134
134 Migration and Risk of Autism and Intellectual Disability – Preliminary Findings from the Stockholm Youth Cohort
C. Magnusson H. Heuvelman M. Morinaga A. C. Hollander C. Dalman D. Rai
11:30 AM
184.135
135 Neonatal Markers of Infant Behavior and Quantitative Traits Related to Autism Spectrum Disorders in a Longitudinal Birth Cohort Study
S. Sagiv K. Kogut Y. S. Kim J. Deardorff B. Eskenazi
11:30 AM
184.136
136 Placental Trophoblast Inclusions Do Not Predict Adverse Neurodevelopment in the Marbles High-Risk Pregnancy Cohort
C. K. Walker K. Kim S. Ozonoff I. Hertz-Picciotto
11:30 AM
184.137
137 Predictors and Impact of Non-Response in a Population-Based Case Control Study: Findings from the Georgia Study to Explore Early Development
L. Schieve S. Harris M. J. Maenner A. Alexander N. Dowling
11:30 AM
184.138
138 Quantitative Autistic Traits Index Silently Transmitted ASD Risk across Generations
M. V. Wong D. Gray N. Marrus J. N. Constantino
11:30 AM
184.139
139 Recruitment Strategies for SPARK in Oregon
E. Fombonne L. D. Pacheco S. Mastel B. J. O'Roak L. Huang-Storms K. Headrick L. McMahan
11:30 AM
184.140
140 Testing the Limits of the SRS-2: Understanding Psychometric Limitations and How the Revised Short Form May Help in Some Ways
A. Kaat C. Farmer V. Hus Bal A. Thurm S. Bishop
11:30 AM
184.141
141 Time Windows of Exposure to Neonicotinoids in Parents of Autistic Children
E. Diamond J. M. Diamond
See more of: Epidemiology
<< Previous Panel | Next Panel >>